FIGURE

Figure 6

ID
ZDB-FIG-220416-72
Publication
Tonon et al., 2022 - 5-Azacytidine Downregulates the Proliferation and Migration of Hepatocellular Carcinoma Cells In Vitro and In Vivo by Targeting miR-139-5p/ROCK2 Pathway
Other Figures
All Figure Page
Back to All Figure Page
Figure 6

Effects of 5-Aza and miR-139-5p on cyclin D1 and E2F1 expression. (a) Effects of 5-Aza on cyclin D1 protein level in JHH-6. Left, representative Western blot (GAPDH was introduced for normalization); right, data normalized to GAPDH levels and to the average of non-treated cells (NTC) are reported in % as mean ± SEM, n = 5; NTC vs./6 μM, * p = 0.0005. (b) Effects of 5-Aza on cyclin D1 protein level in HuH-7. Left, representative Western blot; right, data normalized to GAPDH levels and to the average of NTC are reported in % as mean ± SEM, n = 6; NTC vs. 30 μM, * p = 0.048. (c) Effects of miR-139-5p on cyclin D1 protein level in JHH-6. Left, representative Western blot; right, data normalized to GAPDH levels and to the average of scr (scrambled miR treated cells) are reported in % as mean ± SEM, n = 4; scr vs. miR-139-5p-treated cells, * p = 0.048. (d) Effects of miR-139-5p on cyclin D1 protein level in HuH-7. Left, representative Western blot; right, data normalized to GAPDH levels and to the average of scr are reported in % as mean ± SEM, n = 5; scr vs. miR-139-5p-treated cells, * p = 0.045. (e) Effects of 5-Aza on E2F1 protein level in JHH-6. Left, representative Western blot; right, data normalized to GAPDH levels and to the average of NTC are reported in % as mean ± SEM, n = 3; NTC vs. 6 μM, * p = 0.048. (f) Effects of 5-Aza on E2F1 protein level in HuH-7. Left, representative Western blot; right, data normalized to GAPDH levels and to the average of NTC are reported in % as mean ± SEM, n = 3; NTC vs. 30 μM, * p = 0.044. (g) Effects of miR-139-5p on E2F1 protein level in JHH-6. Left, representative Western blot; right, data normalized to GAPDH levels and to the average of scr are reported in % as mean ± SEM, n = 3; scr vs. miR-139-5p-treated cells, * p = 0.04. (h) Effects of miR-139-5p on E2F1 protein level in HuH-7. Left, representative Western blot; right, data normalized to GAPDH levels and to the average of scr are reported in % as mean ± SEM, n = 3; scr vs. miR-139-5p-treated cells, * p = 0.015. (i) E2F1 mRNA levels following ROCK2 overexpression. Left JHH-6, data normalized to 28S levels and to the average of pEGFP (control plasmid, cells overexpressing EGFP) are reported in % as mean ± SEM, n = 4; pEGFP vs. pROCK2 (cells overexpressing ROCK2), * p = 0.028. Right: HuH-7, data normalized to 28S levels and to the average of pEGFP are reported in % as mean ± SEM, n = 4; pEGFP vs. pROCK2, #p = 0.028. (j) Effects of E2F1 overexpression on the number of 5-Aza-treated cells. Left: data in %, normalized to the average of JHH-6 overexpressing EGFP + 5-Aza treatment, are expressed as mean ± SEM, n = 4; JHH-6 overexpressing E2F1 + 5-Aza vs. JHH-6 overexpressing EGFP + 5-Aza, * p = 0.047. Right: data in %, normalized to the average of HuH-7 overexpressing EGFP + 5-Aza, are expressed as mean ± SEM, n = 4; HuH-7 overexpressing E2F1 + 5-Aza vs. HuH-7 overexpressing EGFP + 5-Aza, #p = 0.032.

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Cancers